These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9437614)

  • 1. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP).
    French MT; Dunlap LJ; Zarkin GA; McGeary KA; McLellan AT
    J Subst Abuse Treat; 1997; 14(5):445-55. PubMed ID: 9437614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the economic cost of substance abuse treatment.
    French MT; McGeary KA
    Health Econ; 1997; 6(5):539-44. PubMed ID: 9353658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using cost and financing instruments for economic evaluation of substance abuse treatment services.
    Salomé HJ; French MT
    Recent Dev Alcohol; 2001; 15():253-69. PubMed ID: 11449745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.
    French MT; Salomé HJ; Sindelar JL; McLellan AT
    Health Serv Res; 2002 Apr; 37(2):433-55. PubMed ID: 12036002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).
    Salomé HJ; French MT; Miller M; McLellan AT
    Drug Alcohol Depend; 2003 Aug; 71(2):195-206. PubMed ID: 12927658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost estimation when time and resources are limited: the Brief DATCAP.
    French MT; Roebuck MC; McLellan AT
    J Subst Abuse Treat; 2004 Oct; 27(3):187-93. PubMed ID: 15501371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of alternative staff time data collection methods on drug treatment service cost estimates.
    Zarkin GA; Dunlap LJ; Wedehase B; Cowell AJ
    Eval Program Plann; 2008 Nov; 31(4):427-35. PubMed ID: 18640722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement.
    French MT; Popovici I; Tapsell L
    J Subst Abuse Treat; 2008 Dec; 35(4):462-9. PubMed ID: 18294803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financing and cost of standard and enhanced methadone treatment.
    Bradley CJ; French MT; Rachal JV
    J Subst Abuse Treat; 1994; 11(5):433-42. PubMed ID: 7869464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining variation in treatment costs: a cost function for outpatient methadone treatment programs.
    Dunlap LJ; Zarkin GA; Cowell AJ
    Health Serv Res; 2008 Jun; 43(3):931-50. PubMed ID: 18454774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of drug abuse treatment programs: methodology and findings.
    French MT
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):111-35. PubMed ID: 7762538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program.
    Roebuck MC; French MT; McLellan AT
    J Subst Abuse Treat; 2003 Jul; 25(1):51-7. PubMed ID: 14512108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Service-level costing of drug abuse treatment.
    Anderson DW; Bowland BJ; Cartwright WS; Bassin G
    J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
    Cartwright WS
    J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economics of public health: financing drug abuse treatment services.
    Cartwright WS; Solano PL
    Health Policy; 2003 Dec; 66(3):247-60. PubMed ID: 14637010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Cost Analysis Tool (TCAT) for estimating costs of outpatient treatment services.
    Flynn PM; Broome KM; Beaston-Blaakman A; Knight DK; Horgan CM; Shepard DS
    Drug Alcohol Depend; 2009 Feb; 100(1-2):47-53. PubMed ID: 19004576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public policy, attitudes and willingness to pay for treatment of substance dependence in Iran.
    Ahmadian Moghaddam S; Mazyaki A; Razaghi EM
    Int J Drug Policy; 2019 Dec; 74():84-89. PubMed ID: 31585318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.